Clinical Trial Update: DEBOXA for Inoperable NET Liver Metastases [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for DEBOXA in inoperable neuroendocrine tumor liver metastases, spanning Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Metastasis
• Neuroendocrine Tumor

Drugs mentioned

• DEBOXA

Snippet

Sponsor: Xiangya Hospital of Central South University | Conditions: Neuroendocrine Tumors, Neoplasm Metastasis | Phase 1, Phase 2 | Status: UNKNOWN